Supplementary Data from Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality among Patients with Early Stage ER-Positive Breast Cancer

Supplementary Table S1. Characteristics of male breast cancer patients by receipt of Oncotype DX Recurrence Score (RS) testing Supplementary Table S2. HRs (95% CI) for total mortality associated with the Recurrence Score categories among patients {less than or equal to} 50 years Supplementary Table S3. HRs (95% CI) for total mortality associated with the Recurrence Score categories among patients > 50 years Supplementary Table S4. HRs (95% CI) for total mortality associated with chemotherapy status among intermediate-risk patients by age Supplementary Table S5. HRs (95% CI) for total mortality associated with Recurrence Score categories (sensitivity analysis)